Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06955845
NA

Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) Therapy Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the Treatment of Post-Traumatic Stress Disorder

Sponsor: Asad Ullah Jan

View on ClinicalTrials.gov

Summary

This randomized controlled trial aims to compare the efficacy of Eye Movement Desensitization and Reprocessing (EMDR) therapy versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the treatment of Post-Traumatic Stress Disorder (PTSD). Adult patients diagnosed with PTSD will be randomly assigned to receive either EMDR therapy or SSRIs for a period of six weeks. The primary outcome is the rate of remission as measured by validated PTSD symptom severity scales at Week 6. Secondary outcomes include changes in functional impairment and patient-reported quality of life. The study seeks to determine whether EMDR therapy is a non-pharmacological alternative to SSRIs for achieving symptom remission in PTSD.

Official title: Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) Therapy Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the Treatment of Post-Traumatic Stress Disorder: A Randomized Controlled Trial

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-05-06

Completion Date

2025-12-31

Last Updated

2025-07-09

Healthy Volunteers

No

Interventions

BEHAVIORAL

Eye Movement Desensitization and Reprocessing Therapy

Patients in this arm will receive weekly EMDR sessions for 6 weeks

DRUG

Selective serotonin reuptake inhibitors

The patients will receive an SSRI medication daily for 6 weeks. The dose will be titrated by the clinician.

Locations (2)

Combined Military Hospital

Nowshera, KPK, Pakistan

Department of Psychiatry, Combined Military Hospital Nowshera

Nowshera, Kpk, Pakistan